{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:27:40Z","timestamp":1791779260303,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Project of \u201cXing-lin Scholars\u201d of Chengdu University of Traditional Chinese Medicine","award":["CGZH2018001"],"award-info":[{"award-number":["CGZH2018001"]}]},{"name":"the Project of \u201cXing-lin Scholars\u201d of Chengdu University of Traditional Chinese Medicine","award":["QNXZ2019017"],"award-info":[{"award-number":["QNXZ2019017"]}]},{"name":"the Project of \u201cXing-lin Scholars\u201d of Chengdu University of Traditional Chinese Medicine","award":["QNXZ2020003"],"award-info":[{"award-number":["QNXZ2020003"]}]},{"name":"the \u201cHundred Talents Program\u201d of the Hospital of Chengdu University of TCM","award":["20-B01"],"award-info":[{"award-number":["20-B01"]}]},{"name":"the \u201cHundred Talents Program\u201d of the Hospital of Chengdu University of TCM","award":["21-Y17"],"award-info":[{"award-number":["21-Y17"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174346"],"award-info":[{"award-number":["82174346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Sichuan Administration of traditional Chinese Medicine","award":["2021MS104"],"award-info":[{"award-number":["2021MS104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current data indicate that supplements such as folic acid and vitamin B may be beneficial in halting and even reversing atrophic gastritis, intestinal metaplasia and intraepithelial neoplasia, generally referred to as gastric precancerous conditions(GPC). However, there is no Meta-analysis article to evaluate the prevention and treatment of folic acid in the gastric precancerous conditions. We therefore conducted a meta-analysis to confirm the efficacy of folic acid in treating GPC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a systematic review method, consider randomized controlled trials (RCT), including clinical trial reports, unpublished clinical trial data, and conference papers. The search time was been set from the database\u2019s establishment to June 2, 2021. The language was not limited, using PubMed, SinoMed, Lancet, Web of Science, CNKI, Cochrane, Ovid, Science Direct, Embase, and EBSCO databases. Data were extracted using a pre-designed extraction tool and analysis was undertaken using RevMan5.2.Besides,we use Origin software to construct the Time-dose interval analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 225 records identified, 13 studies involving 1252 patients (including 11 clinical controlled trials, 1 conference paper report and 1 unpublished research report) met the inclusion conditions. Folic acid dose maintained at 20\u201330\u00a0mg<jats:italic> \/ d<\/jats:italic> for 3\u20136\u00a0months may be beneficial to pathological changes of GPC. Moreover, in the 3\u00a0month treatment of 5 trials, the effect was more obvious when the folic acid dose was maintained at 30\u00a0mg<jats:italic> \/ d<\/jats:italic>. In the 7 trials, the symptom ineffective rate of GPC treated with folic acid was 32% (<jats:italic>RR:0.32, 95%<\/jats:italic> confidence interval\u00a0<jats:italic>CI:0.21\u20130.48),<\/jats:italic> which was combined using a fixed analysis model; The effect of folic acid on gastric mucosal atrophy in 5 trials <jats:italic>(RR: 1.61, 95%CI 1.07\u20132.41)<\/jats:italic>. The changes of folic acid on intestinal metaplasia in the 2 experiments (<jats:italic>RR: 1.77, 95% CI: 1.32\u20132.37)<\/jats:italic>.The 2 results are combined using a fixed analytical model. However, the subgroup analysis of 9 trials revealed no significant effectiveness of symptom.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our research showed that folic acid supplementation brings benefits in preventing and even reversing the progression of GPC in the stomach, and provided evidence for its potential clinical use in management of GPC.<\/jats:p>\n                <jats:p><jats:bold><jats:italic>Registration:<\/jats:italic><\/jats:bold> The logn number of our Meta-anlysis on PROSPERO is CRD420223062.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02390-y","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:06:23Z","timestamp":1659431183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fugang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"2390_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/carcin\/20.12.2195","volume":"20","author":"CT Stadtlander","year":"1999","unstructured":"Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis. 1999;20:2195\u2013208.","journal-title":"Carcinogenesis"},{"key":"2390_CR2","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/00004836-200305001-00006","volume":"36","author":"CR Kapadia","year":"2003","unstructured":"Kapadia CR. Gastric atrophy, metaplasia and dysplasia: a clinical per-spective. J Clin Gastroenterol. 2003;36:S29-36.","journal-title":"J Clin Gastroenterol"},{"key":"2390_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Laur\u00e8n","year":"1965","unstructured":"Laur\u00e8n P. The two histological main types of gastric carcinoma: dif-fuse and so-called intestinal-type carcinoma. Acta Pathol MicrobiolScand. 1965;64:31\u201349.","journal-title":"Acta Pathol MicrobiolScand"},{"key":"2390_CR4","doi-asserted-by":"crossref","unstructured":"Fukao A, Hisamichi S, Ohsato N et al. Correlation between the preva-lence of gastritis and gastric cancer in Japan. Cancer Causes Control1993; 4: 17.20.","DOI":"10.1007\/BF00051709"},{"key":"2390_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2036.1998.00003.x","volume":"12","author":"RM Genta","year":"1998","unstructured":"Genta RM. Gastric atrophy and atrophic gastritis \u2013 nebulous concepts in search of a definition. Aliment Pharmacol Ther. 1998;12:17\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"2390_CR6","doi-asserted-by":"crossref","unstructured":"Dai Yuanyuan, Ye zhengdeng, Huang Huanhuan. Effect of Helicobacter pylori eradication therapy combined with folic acid on chronic hepatitis B Long term effects in patients with atrophic gastritis [J]. World Chinese Journal of digestion, 2017,25(19):1777\u20131782.","DOI":"10.11569\/wcjd.v25.i19.1777"},{"issue":"1","key":"2390_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000443995","volume":"3","author":"XJ Cheng","year":"2016","unstructured":"Cheng XJ, Lin JC, Tu SP. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors. 2016;3(1):25\u201336.","journal-title":"Gastrointest Tumors."},{"key":"2390_CR8","first-page":"2770","volume":"23","author":"L Lihua","year":"2005","unstructured":"Lihua L, Fangxin Z. DNA methylation status and folic acid in gastric precancerous lesions. World Chin J Digest. 2005;23:2770\u20132.","journal-title":"World Chin J Digest"},{"key":"2390_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/gut.49.1.2","volume":"49","author":"MF Dixon","year":"2001","unstructured":"Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut. 2001;49:2\u20134.","journal-title":"Gut"},{"issue":"3","key":"2390_CR10","first-page":"402","volume":"3","author":"WQ Chen","year":"2014","unstructured":"Chen WQ, Zheng RS, Zhang SW, Zeng HM, Zou XN. The incidences and mortalities of major cancers in China, 2010. Chin J Cancer. 2014;3(3):402\u20135.","journal-title":"Chin J Cancer"},{"issue":"6","key":"2390_CR11","first-page":"506","volume":"39","author":"Du Guo Jiyao","year":"2019","unstructured":"Guo Jiyao Du, Yiqi LZ. Eradication of Helicobacter pylori is the only way to reduce the incidence of gastric cancer. Chin J Pract Internal Med. 2019;39(6):506\u201310 ((in chinese)).","journal-title":"Chin J Pract Internal Med"},{"key":"2390_CR12","first-page":"313","volume":"206","author":"I Eto","year":"1986","unstructured":"Eto I, Krumdieck CL. Role of vitamin B12 and folate deficien-cies in carcinogenesis. Adv Exp Med Biol. 1986;206:313\u201330.","journal-title":"Adv Exp Med Biol"},{"key":"2390_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jn\/130.2.129","volume":"130","author":"SW Choi","year":"2000","unstructured":"Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130:129\u201332.","journal-title":"J Nutr"},{"issue":"11","key":"2390_CR14","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3748\/wjg.v11.i11.1571","volume":"11","author":"DZ Cao","year":"2005","unstructured":"Cao DZ, Sun WH, Ou XL, Yu Q, Yu T, Zhang YZ, Cheng YL. Effects of folic acid on epithelial apoptosis and expression of Bcl-2 and p53 in premalignant gastric lesions. World J Gastroenterol WJG. 2005;11(11):1571.","journal-title":"World J Gastroenterol WJG"},{"issue":"5","key":"2390_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s005350050152","volume":"33","author":"JY Fang","year":"1998","unstructured":"Fang JY, Xiao SD. Effect of trans-retinoic acid and folic acid on apoptosis in human gastric cancer cell lines MKN-45 and MKN-28. J Gastroenterol. 1998;33(5):656\u201361.","journal-title":"J Gastroenterol"},{"key":"2390_CR16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collabo-ration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"2390_CR17","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(7): e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"4","key":"2390_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau JM, Barros R, Fl\u00e9jou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365\u201388. https:\/\/doi.org\/10.1055\/a-0859-1883 (Epub 2019 Mar 6 PMID: 30841008).","journal-title":"Endoscopy"},{"key":"2390_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40798-021-00374-y","volume":"8","author":"J Berezanskaya","year":"2022","unstructured":"Berezanskaya J, Cade W, Best TM, et al. ADHD prescription medications and their effect on athletic performance: a systematic review and meta-analysis. Sports Med Open. 2022;8:5. https:\/\/doi.org\/10.1186\/s40798-021-00374-y.","journal-title":"Sports Med Open"},{"key":"2390_CR20","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Higgins JPT, Green S (eds). The Cochrane Collaboration, 2011."},{"key":"2390_CR21","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration. RevMan 5.3 User Guide. The Nordic Cochrane Centre: The Cochrane Collaboration, 2014. https:\/\/tinyurl.com\/y563d5mq (accessed 30 July 2020)."},{"issue":"2","key":"2390_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/01635581.2015.989375","volume":"67","author":"SC Chang","year":"2015","unstructured":"Chang SC, Goldstein BY, Mu L, et al. Plasma folate, vitamin B12, and homocysteine and cancers of the esophagus, stomach, and liver in a Chinese population. Nutr Cancer. 2015;67(2):212\u201323.","journal-title":"Nutr Cancer"},{"key":"2390_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0895-4356(91)90261-7","volume":"44","author":"JL Fleiss","year":"1991","unstructured":"Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol. 1991;44:127\u201339.","journal-title":"J Clin Epidemiol"},{"key":"2390_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"2390_CR25","first-page":"105","volume":"29","author":"Y Meng","year":"2019","unstructured":"Meng Y. Keyword: folic acid Helicobacter pylori, eradication, chronic atrophic gastritis. Abstract Latest World Med Inf. 2019;29:105\u20136 ((in chinese)).","journal-title":"Abstract Latest World Med Inf"},{"key":"2390_CR26","first-page":"116","volume":"13","author":"Z Zhimin","year":"2019","unstructured":"Zhimin Z. Folic acid combined with Helicobacter pylori eradication in the treatment of chronic atrophic gastritis. Electron J Gen Stomatol. 2019;13:116.","journal-title":"Electron J Gen Stomatol"},{"key":"2390_CR27","unstructured":"Feng M, Huang F, Zhou J. Observation of the curative effect of folic acid on the pre-lesions of chronic atrophic gastritis. J Clin Psychosom Dis, 2015, 21(1): 79 (in chinese)"},{"issue":"11","key":"2390_CR28","first-page":"1283","volume":"44","author":"Y Wu","year":"2018","unstructured":"Wu Y, Liu H, Chai X. Folic acid combined with Helicobacter pylori eradication in the treatment of chronic atrophic gastritis patients with disease progression and mucosal outcome influencing factors analysis. Jiangsu Med. 2018;44(11):1283\u20136 ((in chinese)).","journal-title":"Jiangsu Med"},{"issue":"5","key":"2390_CR29","first-page":"70","volume":"12","author":"L Kong","year":"2017","unstructured":"Kong L. Efficacy analysis of folic acid combined with Helicobacter pylori eradication in the treatment of patients with chronic atrophic gastritis. Chin Pharmaceut Econ. 2017;12(5):70\u20132 ((in chinese)).","journal-title":"Chin Pharmaceut Econ"},{"issue":"5","key":"2390_CR30","first-page":"689","volume":"29","author":"S Wei","year":"2016","unstructured":"Wei S. Clinical analysis of folic acid combined with Helicobacter pylori eradication in the treatment of chronic atrophic gastritis. J Math Med. 2016;29(5):689\u201390 ((in chinese)).","journal-title":"J Math Med"},{"key":"2390_CR31","first-page":"206","volume":"12","author":"Q Yi","year":"2018","unstructured":"Yi Q. The effect of folic acid combined with Helicobacter pylori eradication in the treatment of patients with chronic atrophic gastritis. Famous doctor. 2018;12:206\u20137 ((in chinese)).","journal-title":"Famous doctor"},{"key":"2390_CR32","first-page":"29","volume":"09","author":"J Xiaozhong","year":"2014","unstructured":"Xiaozhong J, Shuwen Y, Yanmin Z, Jie Z, Heli D. Clinical observation of folic acid combined with Helicobacter pylori eradication in the treatment of chronic atrophic gastritis. Chin Commun Phys. 2014;09:29\u201330 ((in chinese)).","journal-title":"Chin Commun Phys"},{"key":"2390_CR33","first-page":"768","volume":"11","author":"Z Yongqiang","year":"2015","unstructured":"Yongqiang Z, Pengfei L. Study on the outcome of gastric rejuvenation and folic acid combined therapy on gastric precancerous lesions after Helicobacter pylori eradication. Chin J Integr Tradit Chin Western Med Digest. 2015;11:768\u201372 ((in chinese)).","journal-title":"Chin J Integr Tradit Chin Western Med Digest"},{"issue":"29","key":"2390_CR34","first-page":"150","volume":"10","author":"J Yang","year":"2018","unstructured":"Yang J, Zhao X, Liu X. Clinical observation of folic acid combined with traditional Chinese medicine in the treatment of chronic atrophic gastritis. Chin Contin Med Educ. 2018;10(29):150\u20132 ((in chinese)).","journal-title":"Chin Contin Med Educ"},{"key":"2390_CR35","first-page":"54","volume":"10","author":"Wu Jia Daoquan","year":"2002","unstructured":"Jia Daoquan Wu, Weiguo LC, Zhiqiang W, Chengjun Y. Effect of folic acid in the treatment of chronic atrophic gastritis. Chin J Digest. 2002;10:54\u20135 ((in chinese)).","journal-title":"Chin J Digest"},{"key":"2390_CR36","unstructured":"Liu S. A randomized, folic acid-controlled clinical study on the treatment of gastric precancerous lesions with traditional Chinese medicine. Spleen and Stomach Disease Branch of Chinese Society of Traditional Chinese Medicine. The 23rd National Spleen and Stomach Disease Academic Exchange Conference Paper Collection. Spleen and Stomach Disease Branch of Chinese Society of Traditional Chinese Medicine:,2011:5."},{"key":"2390_CR37","doi-asserted-by":"crossref","unstructured":"Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A, Cesaro P, Lenti MV, Annibale B, Corazza GR. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51(12):1621\u20131632","DOI":"10.1016\/j.dld.2019.09.016"},{"key":"2390_CR38","doi-asserted-by":"publisher","first-page":"3731S","DOI":"10.1093\/jn\/133.11.3731S","volume":"133","author":"YI Kim","year":"2003","unstructured":"Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S-3739S.","journal-title":"J Nutr"},{"issue":"7","key":"2390_CR39","first-page":"437","volume":"32","author":"T Chunli","year":"2012","unstructured":"Chunli T, Bing Z, Xueying T, et al. Efficacy of folic acid combined with Helicobacter pylori eradication in the treatment of chronic atrophic gastritis. Chin J Digest. 2012;32(7):437\u201340 ((in chinese)).","journal-title":"Chin J Digest"},{"issue":"1","key":"2390_CR40","first-page":"7","volume":"24","author":"D Ping","year":"2015","unstructured":"Ping D, Haiying P, Gao Lu, et al. Study on folic acid modification of recombinant Apoptin and its apoptosis-inducing activity of tumor cells. Chin Convalescent Med. 2015;24(1):7\u20139 ((in chinese)).","journal-title":"Chin Convalescent Med"},{"issue":"2","key":"2390_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1523-5378.2008.00592.x","volume":"13","author":"JM Kang","year":"2010","unstructured":"Kang JM, Kim N, Yoo JY, et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter. 2010;13(2):146\u201356.","journal-title":"Helicobacter"},{"issue":"2","key":"2390_CR42","first-page":"73","volume":"7","author":"S Zhu","year":"2002","unstructured":"Zhu S, Mason J, Shi Y, et al. The intervention effect of folic acid on the occurrence of gastric cancer and other gastrointestinal cancers \u2013- seven-year follow-up of clinical trials. Gastroenterology. 2002;7(2):73\u20138.","journal-title":"Gastroenterology"},{"key":"2390_CR43","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/jnci\/djj264","volume":"98","author":"WC You","year":"2006","unstructured":"You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Gail MH. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974\u201383.","journal-title":"J Natl Cancer Inst"},{"key":"2390_CR44","doi-asserted-by":"crossref","unstructured":"KIM Y I.Role of folate in colon cancer development and progression. J Nutr, 2003, 133 (11S1) :3731S-3739S.","DOI":"10.1093\/jn\/133.11.3731S"},{"issue":"2","key":"2390_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1039\/ajcn\/nqx076","volume":"107","author":"YI Kim","year":"2018","unstructured":"Kim YI. Folate and cancer:a tale of Dr. Jekyll and Mr. Hyde? Am J Clin Nutr. 2018;107(2):139\u201342. https:\/\/doi.org\/10.1039\/ajcn\/nqx076.","journal-title":"Am J Clin Nutr"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02390-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:13:41Z","timestamp":1659431621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02390-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2390"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02390-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"370"}}